Email
Print
1. Imatinib Drug Market - Overview
1.1 Definitions and Scope
2. Imatinib Drug Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Imatinib Drug Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Imatinib Drug Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Imatinib Drug Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Imatinib Drug Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Imatinib Drug Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
11.1 Imatinib Drug Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Imatinib Drug- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Imatinib Drug- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Imatinib Drug - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Imatinib Drug - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Imatinib Drug Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Imatinib Drug Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Imatinib Drug Market - Key Company List by Country Premium
15. Imatinib Drug Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Actavis Generic
15.3 Apotex Inc
15.4 Cipla Inc
15.5 Dr. Reddy'S Laboratory
15.6 Glenmark Pharmaceutical Ltd
15.7 Mylan Pharms Inc
15.8 Novartis
15.9 Sanofi S A
15.10 Sun Pharmaceutical
15.11 Teva Pharmaceutical Industry Ltd
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Imatinib Drug Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Imatinib Drug Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Imatinib Drug Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Imatinib Drug Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Imatinib Drug Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Imatinib Drug Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Imatinib Drug Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Imatinib Drug Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Imatinib Drug Market - By Drug Formulation (Market Size -$Million / $Billion)
9.1 Tablet
9.2 Capsule
10. Imatinib Drug - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Aggressive Systemic Mastocytosis
10.3.2 Chronic Eosinophilic Leukemia
10.3.3 Dermatofibrosarcoma Protuberans
10.3.4 Gastrointestinal Stromal Tumor
10.3.5 Hyper-Eosinophilic Syndrome
10.3.6 Myelodysplastic Syndrome
10.3.7 Myeloproliferative Disease
10.3.8 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
10.3.9 Philadelphia Chromosome Positive Chronic Myeloid Leukemia
11. Imatinib Drug- By Geography (Market Size -$Million / $Billion)11.1 Imatinib Drug Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Imatinib Drug- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Imatinib Drug- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Imatinib Drug - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Imatinib Drug - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Imatinib Drug Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Imatinib Drug Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Imatinib Drug Market - Key Company List by Country Premium
15. Imatinib Drug Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Actavis Generic
15.3 Apotex Inc
15.4 Cipla Inc
15.5 Dr. Reddy'S Laboratory
15.6 Glenmark Pharmaceutical Ltd
15.7 Mylan Pharms Inc
15.8 Novartis
15.9 Sanofi S A
15.10 Sun Pharmaceutical
15.11 Teva Pharmaceutical Industry Ltd
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Imatinib Drug Market - Appendix16.1 Abbreviations
16.2 Sources
17. Imatinib Drug Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Imatinib Drug Market, By Drug Formulation Market 2023-2030 ($M)1.1 Tablet Market 2023-2030 ($M) - Global Industry Research
1.2 Capsule Market 2023-2030 ($M) - Global Industry Research
2.Global Imatinib Drug Market, By Drug Formulation Market 2023-2030 (Volume/Units)
2.1 Tablet Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Capsule Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Imatinib Drug Market, By Drug Formulation Market 2023-2030 ($M)
3.1 Tablet Market 2023-2030 ($M) - Regional Industry Research
3.2 Capsule Market 2023-2030 ($M) - Regional Industry Research
4.South America Imatinib Drug Market, By Drug Formulation Market 2023-2030 ($M)
4.1 Tablet Market 2023-2030 ($M) - Regional Industry Research
4.2 Capsule Market 2023-2030 ($M) - Regional Industry Research
5.Europe Imatinib Drug Market, By Drug Formulation Market 2023-2030 ($M)
5.1 Tablet Market 2023-2030 ($M) - Regional Industry Research
5.2 Capsule Market 2023-2030 ($M) - Regional Industry Research
6.APAC Imatinib Drug Market, By Drug Formulation Market 2023-2030 ($M)
6.1 Tablet Market 2023-2030 ($M) - Regional Industry Research
6.2 Capsule Market 2023-2030 ($M) - Regional Industry Research
7.MENA Imatinib Drug Market, By Drug Formulation Market 2023-2030 ($M)
7.1 Tablet Market 2023-2030 ($M) - Regional Industry Research
7.2 Capsule Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Imatinib Drug Market Revenue, 2023-2030 ($M)2.Canada Imatinib Drug Market Revenue, 2023-2030 ($M)
3.Mexico Imatinib Drug Market Revenue, 2023-2030 ($M)
4.Brazil Imatinib Drug Market Revenue, 2023-2030 ($M)
5.Argentina Imatinib Drug Market Revenue, 2023-2030 ($M)
6.Peru Imatinib Drug Market Revenue, 2023-2030 ($M)
7.Colombia Imatinib Drug Market Revenue, 2023-2030 ($M)
8.Chile Imatinib Drug Market Revenue, 2023-2030 ($M)
9.Rest of South America Imatinib Drug Market Revenue, 2023-2030 ($M)
10.UK Imatinib Drug Market Revenue, 2023-2030 ($M)
11.Germany Imatinib Drug Market Revenue, 2023-2030 ($M)
12.France Imatinib Drug Market Revenue, 2023-2030 ($M)
13.Italy Imatinib Drug Market Revenue, 2023-2030 ($M)
14.Spain Imatinib Drug Market Revenue, 2023-2030 ($M)
15.Rest of Europe Imatinib Drug Market Revenue, 2023-2030 ($M)
16.China Imatinib Drug Market Revenue, 2023-2030 ($M)
17.India Imatinib Drug Market Revenue, 2023-2030 ($M)
18.Japan Imatinib Drug Market Revenue, 2023-2030 ($M)
19.South Korea Imatinib Drug Market Revenue, 2023-2030 ($M)
20.South Africa Imatinib Drug Market Revenue, 2023-2030 ($M)
21.North America Imatinib Drug By Application
22.South America Imatinib Drug By Application
23.Europe Imatinib Drug By Application
24.APAC Imatinib Drug By Application
25.MENA Imatinib Drug By Application
26.Novartis, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Glenmark Pharmaceutical Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Sun Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Actavis Generic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Dr. Reddy'S Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Teva Pharmaceutical Industry Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Sanofi S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Cipla Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Apotex Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Mylan Pharms Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)